Cargando…

Anti-Cancer Effect of IN-2001 in T47D Human Breast Cancer

Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and have a key role in the epigenetic regulation of gene expression. Histone deacetylase (HDAC) inhibitors are emerging as an exciting new class of potential anti-cancer agents. In recent years, a number of structural...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joung, Ki Eun, Min, Kyung Nan, Kim, Dae-Kee, Sheen, Yhun Yhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792206/ https://www.ncbi.nlm.nih.gov/pubmed/24116279 http://dx.doi.org/10.4062/biomolther.2012.20.1.081

Ejemplares similares

Anti-Cancer Effect of IN-2001 in MDA-MB-231 Human Breast Cancer
por: Min, Kyung Nan, et al.
Publicado: (2012)

Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
por: Min, Kyung Nan, et al.
Publicado: (2012)

Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
por: Park, So-Yeon, et al.
Publicado: (2015)

Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor
por: Park, Jiyoung, et al.
Publicado: (2022)

Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
por: Sheen, Yhun Yhong, et al.
Publicado: (2013)

TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling
por: Park, Sang-A, et al.
Publicado: (2015)

Draft budget of the Organization for the 47th financial year 2001
Publicado: (2000)

Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells
por: Mooney, L M, et al.
Publicado: (2002)

Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro
por: Behroozeh, Aras, et al.
Publicado: (2018)

Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells
por: Maasomi, Zahra Javan, et al.
Publicado: (2017)

Apoptosis induction on human breast cancer T47D cell line by extracts of Ancorina sp.
por: Tunjung, Woro Anindito Sri, et al.
Publicado: (2019)

Synthesis of novel 1,8-acridinediones derivatives: Investigation of MDR reversibility on breast cancer cell lines T47D and tamoxifen-resistant T47D
por: Moallem, S.A., et al.
Publicado: (2015)

Cytotoxic Activity of BornUSU I towards T47D Breast Cancer Cells
por: Nasution, Nadiya Anandita, et al.
Publicado: (2019)

Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7
por: Adjo Aka, Juliette, et al.
Publicado: (2012)

Evaluation of Metastasis Suppressor Genes Expression and In Vitro Anti-Cancer Effects of Zinc Oxide Nanoparticles in Human Breast Cancer Cell Lines MCF-7 and T47D
por: Shandiz, Seyed Ataollah Sadat, et al.
Publicado: (2021)

Novel oral transforming growth factor‐β signaling inhibitor EW‐7197 eradicates CML‐initiating cells
por: Naka, Kazuhito, et al.
Publicado: (2016)

Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton
por: Giretti, Maria Silvia, et al.
Publicado: (2014)

Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone
por: Wright, Roni H. G., et al.
Publicado: (2022)

Correction: Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7
por: Aka, Juliette Adjo, et al.
Publicado: (2012)

Targeting CD47 as a Novel Immunotherapy for Breast Cancer
por: Chen, Can, et al.
Publicado: (2022)

Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells
por: Men, Xin, et al.
Publicado: (2021)

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
por: Liu, Jie, et al.
Publicado: (2015)

Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47–70) and CXCL4L1(47–70) in an EGF-dependent breast cancer model
por: Van Raemdonck, Katrien, et al.
Publicado: (2014)

Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation.
por: Pink, J. J., et al.
Publicado: (1996)

Myricetin Apoptotic Effects on T47D Breast Cancer Cells is a P53-Independent Approach
por: Soleimani, Mitra, et al.
Publicado: (2020)

A fully human anti-CD47 blocking antibody with therapeutic potential for cancer
por: Zeng, Dadi, et al.
Publicado: (2016)

Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action
por: Kampa, Marilena, et al.
Publicado: (2004)

SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D
por: Huang, Wei-Qing, et al.
Publicado: (2010)

The Comparison of The Effects of Silybin and Silybin-Phosphatidylcholine on Viability and ESR Expression in Human Breast Cancer T47D Cell Line
por: Mahmoodi, Narges, et al.
Publicado: (2014)

Characterization of a hormonally induced reverse transcriptase (RT) from the human breast cancer cell line T47D: a possible involvement in human breast cancer
por: Golan, M, et al.
Publicado: (2001)

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
por: Betancur, Paola A., et al.
Publicado: (2017)

Survival from breast cancer in England and Wales up to 2001
por: Leary, A, et al.
Publicado: (2008)

Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
por: Liu, Liang, et al.
Publicado: (2017)

Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells
por: Pang, Haiyan, et al.
Publicado: (2004)

Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer
por: Perez White, Bethany, et al.
Publicado: (2013)

Enhancing the Effects of Low Dose Doxorubicin Treatment by the Radiation in T47D and SKBR3 Breast Cancer Cells
por: Aghaee, Fahimeh, et al.
Publicado: (2013)

Effects of berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines
por: Barzegar, Elmira, et al.
Publicado: (2015)

PCP4/PEP19 promotes migration, invasion and adhesion in human breast cancer MCF-7 and T47D cells
por: Yoshimura, Takuya, et al.
Publicado: (2016)

Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
por: Si, Yingnan, et al.
Publicado: (2021)

Potential New Cancer Immunotherapy: Anti-CD47-SIRPα Antibodies
por: Lu, Quansheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_snoo6d4gtd10qnrs6emu3vaf4d